In a report released today, Jason Mills from Canaccord Genuity maintained a Hold rating on LivaNova PLC (NASDAQ: LIVN), with a price target of $83. The company’s shares opened today at $88.84, close to its 52-week high of $92.80.
According to TipRanks.com, Mills is a top 25 analyst with an average return of 29.8% and a 77.7% success rate. Mills covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Boston Scientific Corp, and Staar Surgical Company.
LivaNova PLC has an analyst consensus of Moderate Buy, with a price target consensus of $98.50.
See today’s analyst top recommended stocks >>
Based on LivaNova PLC’s latest earnings release for the quarter ending March 31, the company reported a quarterly net profit of $13.27 million. In comparison, last year the company had a net profit of $11.27 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
LivaNova Plc is a global medical technology company specializing in the areas of Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management. It provides its services to patients, healthcare professionals and healthcare systems. The company was founded on October 19, 2015 and is headquartered in London, the United Kingdom.
